Countdown to ASLMS 2019!

-2067

Days

-21

Hours

-55

Minutes

Friday, March 29

Basic Science and Translational Research


Participants Clinicians, engineers, scientists, researchers, developers.

Background Requirements Basic knowledge of light-tissue interactions.

Educational Needs/Expected Learning Objectives These sessions will promote understanding of fundamental light-tissue interactions, laboratory evaluation of new technologies and methodologies, and applications of these technologies and methodologies in in-vitro and in-vivo studies. Ideas presented in this session are expected to impact clinical research studies and medical device development. Participants will learn about:

  • Fundamental light-tissue interactions and measurements of tissue properties.
  • Biological response of cells and tissues to energy-based technology (photobiomodulation, radiofrequency, laser/light therapy and cryolipolysis).
  • New diagnostic and treatment approaches.
  • Pre-clinical evaluation of novel therapeutic approaches using light and energy-based devices.
  • Micro-, meso-, and macroscopic approaches to assess the biological tissue response to light and energy-based devices.
  • First-in-man application of light and energy-based technologies.
  • Methods and technologies used for monitoring therapeutic interventions.

Sub-Topics 

  • Diagnostics - Imaging - Skin
  • Therapeutic - Phototherapy - Gastroenterology/Photobiomodulation/Skin Surgery
  • Therapeutic - Skin - Drug Delivery/Plasma
Section Chairs
Walfre Franco, PhD Franco-Walfre-Thumb Fernanda H. Sakamoto, MD, PhD  Sakamoto-Fernanda-H-Thumb
Time  TITLE - PRESENTING AUTHOR
12:30 PM - 12:35 PM Introduction - Fernanda H. Sakamoto, Walfre Franco
Diagnostics - Imaging - Skin
12:36 PM - 12:43 PM IMPROVED NADH FLUORESCENCE LIFETIME ANALYSIS: A LABEL-FREE BIOENERGETIC MARKER FOR ASSESSMENT OF WOUNDS Michael Evers ♦✈ | Cutaneous Biology Research Center, Massachusetts General Hospital, Boston, MA
12:44 PM - 12:46 PM Q&A
12:47 PM - 12:54 PM SPECTRALLY CORRECTED OPTICAL POLARIZATION IMAGING FOR IN VIVO EVALUATION OF SKIN CANCER MARGINS Peter Jermain ♦ | University of Massachusetts Lowell, Lowell, MA
12:55 PM - 12:57 PM Q&A
12:58 PM - 1:05 PM EVALUATION OF FUNGALLY INFECTED NAIL TISSUE USING UV-FLUORESCENCE Vinzent K. Ortner ♦✈ | Bispebjerg Hospital, University of Copenhagen, Copenhagen NV, Copenhagen, Denmark
1:06 PM - 1:08 PM Q&A
1:09 PM - 1:16 PM IMPROVED FOLLICULAR DELIVERY OF MICROPARTICLES FOLLOWING TOPICAL PRETREATMENT VISUALIZED BY OPTICAL IMAGING Vinzent K. Ortner ♦ | Bispebjerg Hospital, University of Copenhagen, Copenhagen NV, Copenhagen, Denmark
1:17 PM - 1:19 PM Q&A
1:20 PM - 1:27 PM ENHANCED OPTICAL CLEARING OF EX VIVOPORCINE SKIN VIA HYPODERMIC NEEDLE ARRAY DEVICES Samantha Corber  | University of California - Riverside, Riverside, CA
1:28 PM - 1:30 PM Q&A
Therapeutic - Phototherapy - Gastroenterology
1:31 PM - 1:38 PM ABLATIVE FRACTIONAL LASER EXPOSURE AS AN ADJUVANT FOR IMMUNOTHERAPY OF COLON CANCER IN A MICE MODEL Masayoshi Kawakubo | Massachusetts General Hospital, Boston, MA
1:39 PM - 1:44 PM Q&A
1:45 PM - 2:30 PM BREAK
Therapeutic - Phototherapy - Photobiomodulation - Skin
2:31 PM - 2:38 PM Best of Session: Basic Science and Translational Research Award Recipient
PHOTOBIOMODULATION AT MULTIPLE WAVELENGTHS DIFFERENTLY MODULATES OXIDATIVE STRESS IN VITRO AND IN VIVO 
Katia Rupel ♦ | University of Trieste, Trieste, Italy
2:39 PM - 2:41 PM Q&A
Therapeutic - Phototherapy - Skin Surgery
2:42 PM - 2:49 PM NEEDLELESS INJECTOR POWERED BY Er:YAG LASER Chang-Hun Huh | Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea
2:50 PM - 2:52 PM Q&A
2:53 PM - 3:00 PM DOSIMETRY DETERMINATION PROCESS FOR THE TREATMENT OF SEBACEOUS GLANDS Emil A. Tanghetti | Center for Dermatology & Laser Surgery, Sacramento, CA
3:01 PM - 3:03 PM Q&A
3:04 PM - 3:11 PM EFFECT OF FRACTIONAL LASER THERAPY ON REDUCING FIBROSIS IN PATIENTS WITH CHRONIC RADIATION DERMATITIS Elizabeth Morehouse ♦ | Massachusetts General Hospital, Boston, MA
3:12 PM - 3:14 PM Q&A
3:15 PM - 3:22 PM THREE SKIN TYPES FOR LASER-ASSISTED DRUG DELIVERY IN FRANZ DIFFUSION CELL MODEL - A COMPARATIVE STUDY Uffe Høgh Olesen ♦ | Bispebjerg Hospital, University of Copenhagen, Copenhagen NV, Copenhagen, Denmark
3:23 PM - 3:25 PM Q&A
3:26 PM - 3:33 PM FOCUSED 1,940nm THULIUM LASER RADIATION TO CREATE ABLATIVE FRACTIONAL SKIN LESIONS Garuna Kositratna | Massachusetts General Hospital, Boston, MA
3:34 PM - 3:36 PM Q&A
Therapeutic - Skin - Plasma
3:37 PM - 3:44 PM HELIUM PLASMA SKIN REGENERATION – EVALUATION OF SKIN TISSUE EFFECTS IN A PORCINE MODEL AND COMPARISON TO NITROGEN PLASMA SKIN REGENERATION J. David Holcomb | Holcomb - Kreithen Plastic Surgery and Dermatology, Sarasota, FL
3:45 PM - 3:47 PM Q&A
Therapeutic - Skin - Drug Delivery 
3:48 PM - 3:55 PM JET-INJECTION ASSISTED DRUG DELIVERY - HISTOLOGICAL CHARACTERIZATION OF CUTANEOUS DEPOSITION Andres M. Erlendsson ♦ | Memorial Sloan Kettering Cancer Center, New York, NY
3:56 PM - 3:58 PM Q&A
3:59 PM - 4:00 PM Conclusion - Fernanda H. Sakamoto, Walfre Franco

CME Max AMA PRA Category 1 CME Credits™, CE Max CE Contact Hours

♦ Early Career Presenter | ✈ ASLMS Educational Grant Recipient
For full abstract author information, please refer to our mobile app.
Schedule and rooms subject to change without notice.

The American Society for Laser Medicine and Surgery, Inc. is the world’s largest scientific organization dedicated to promoting research, education and high standards of clinical care in the field of medical laser applications. It provides a forum for the exchange of scientific information and participation in communicating the latest developments in laser medicine and surgery to clinicians, research investigators, government and regulatory agencies, and the public.

Connect with ASLMS!